Post Time: 2026-03-13

Country: United States, Australia, United Kingdom. City: Mobile, Nashville, Norman, Roseville, VisaliaAbemaciclib (brand names: Verzenio, Ramiven) is an orally administered anti-cancer agent classified as a cyclin-dependent kinase (CDK) 4/6 inhibitor. It is primarily used in the management of hormone receptor-positive (HR+), HER2-negative advanced or metastatic breast cancer. Here's a detailed overview of its pharmacology: Mechanism of Action Abemaciclib selectively inhibits CDK4 and CDK6, enzymes involved in regulating the cell cycle. By inhibiting CDK4/6, abemaciclib blocks the phosphorylation of retinoblastoma (Rb) protein, preventing progression from the G1 phase to the S phase in the cell cycle. This action halts the proliferation of cancer cells that are dependent on CDK4/6 activity, Going at particularly those in hormone receptor-positive breast cancers. Pharmacokinetics Administration: Taken orally, usually in combination with endocrine therapy (e.g., fulvestrant or aromatase inhibitors). Absorption: Well absorbed after oral administration, with peak plasma concentrations achieved in 8 hours. Metabolism: Metabolized in the liver primarily by cytochrome P450 enzyme CYP3A4. Excretion: Eliminated mostly through feces (81%) and urine (3%). Half-Life: The terminal elimination half-life is approximately 18–30 hours, allowing for this post twice-daily dosing. Indications Advanced or Metastatic Breast Cancer: Approved for HR+, HER2-negative breast cancer as: Monotherapy in previously treated patients. Combination therapy with endocrine agents, such as fulvestrant or aromatase inhibitors, to enhance efficacy and delay disease progression. Adverse Effects Hematologic Toxicity: Neutropenia (dose-limiting), anemia, and thrombocytopenia. Gastrointestinal Effects: Diarrhea (most common adverse effect), nausea, vomiting, and abdominal pain. Hepatotoxicity: Elevated liver enzymes (AST/ALT), this requiring regular liver function monitoring. Fatigue and weakness. Other: Infections, decreased appetite, and alopecia. #Abemaciclib